Cleared Traditional

K840967 - OHIO HEAT REFLECTING PATCH

K840967 is an FDA 510(k) clearance for OHIO HEAT REFLECTING PATCH, manufactured by Ohio Medical Products. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 17-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1984
Decision
17d
Days
Class 2
Risk

K840967 is an FDA 510(k) clearance for the OHIO HEAT REFLECTING PATCH. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Ohio Medical Products (Mchenry, US). The FDA issued a Cleared decision on March 23, 1984 after a review of 17 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ohio Medical Products devices

FDA 510(k) Submission Details - K840967

510(k) Number K840967 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 1984
Decision Date March 23, 1984
Days to Decision 17 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
112d faster than avg
Panel avg: 129d · This submission: 17d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 338
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K840967.
UMI CURVED CHEMONUCLEOLYSIS NEEDLE
K842012 · Universal Medical Instrument Corp. · Jul 1984
THINWALL PUNCTURE NEEDLE
K841704 · Meadox Surgimed, Inc. · Jun 1984
HYPODERMIC NEEDLES & STYLETS
K840033 · Microvasive · Apr 1984
CHEMONUCLEOLYSIS NEEDLE
K834436 · Universal Medical Instrument Corp. · Mar 1984
INTRADISCAL THERAPY TRAY
K834553 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Mar 1984
INTRADISCAL THERAPY TRAY
K832858 · Ulti-Med Intl., Inc. · Sep 1983